APA (7th ed.) Citation

Erlangga, Z., & Poth, T. (2019). Potent antitumor activity of liposomal irinotecan in an organoid- and CRISPR-Cas9-based murine model of gallbladder cancer. Cancers, 11(12), . https://doi.org/10.3390/cancers11121904

Chicago Style (17th ed.) Citation

Erlangga, Zulrahman, and Tanja Poth. "Potent Antitumor Activity of Liposomal Irinotecan in an Organoid- and CRISPR-Cas9-based Murine Model of Gallbladder Cancer." Cancers 11, no. 12 (2019). https://doi.org/10.3390/cancers11121904.

MLA (9th ed.) Citation

Erlangga, Zulrahman, and Tanja Poth. "Potent Antitumor Activity of Liposomal Irinotecan in an Organoid- and CRISPR-Cas9-based Murine Model of Gallbladder Cancer." Cancers, vol. 11, no. 12, 2019, https://doi.org/10.3390/cancers11121904.